炎症性肠病 (IBD) 的药物管理:叙述性审查
Priyadarshan Singh1, Paramjit Saini2, Pravin P Kalyankar3
1Internal Medicine, Cambridge Health Alliance, Cambridge, USA.
Cureus
|December 1, 2025
概括
针对特定途径的较新的分子药物为炎症性肠病 (IBD) 管理提供了更好的疗效和更少的副作用. 这些先进的治疗方法考虑了肠道微生物组和肠-大脑轴,以获得更好的患者结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠病 (IBD) 的确切原因尚未完全理解,尽管自身免疫机制也与之有关.
- 传统的免疫调节和抗炎药物已在治疗IBD方面表现出有用性.
- 了解肠道粘膜免疫系统和白细胞贩运的进展使得有针对性的治疗成为可能.
研究的目的:
- 审查IBD的新型治疗药物.
- 探索新药与宿主微生物组和肠-大脑轴的相互作用.
- 在IBD的自身免疫现象中识别新的点.
主要方法:
- 对当前和新兴IBD治疗方法的文献综述.
- 对新药向的分子通路的分析,包括Janus激酶 (JAK) 路径,化酶,介质白蛋白 (IL) -12,23,和选择性蛋白.
- 讨论微生物组和肠-大脑轴在IBD病原和治疗中的作用.
主要成果:
- 针对特定途径的分子药物 (例如,JAK抑制剂,IL-12/23抑制剂) 显著改变了IBD管理.
- 与一些传统疗法相比,这些新药显示出更好的疗效和更少的副作用.
- 新兴的治疗方法为IBD患者提供了有前途的治疗策略,IBD患者对标准治疗没有反应.
结论:
- 包括向分子药物在内的新型治疗策略正在彻底改变IBD治疗.
- 未来的IBD管理可能会将微生物组和肠-大脑轴的考虑与先进的药理干预相结合.
- 这些进展有望改善疾病控制和改善IBD患者的生活质量.
更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
Inflammatory Bowel Disease I: Ulcerative Colitis
862
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862
Inflammatory Bowel Disease V: Surgical Management
428
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
428
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413


